SAMUEL STROBER, M. D.; ELIZABETH FIELD, M.D.; RICHARD T. HOPPE, M.D.; BRIAN L. KOTZIN, M.D.; OVADIA SHEMESH, M.D.; EDGAR ENGLEMAN, M.D.; JON C. ROSS, M.D.; BRYAN D. MYERS, M.D.
Ten patients with lupus nephritis and marked proteinuria (3.9 g or more /d) that did not respond adequately to treatment with prednisone alone or prednisone in combination with azathioprine were treated with total lymphoid irradiation in an uncontrolled feasibility study. Within 6 weeks after the start of total lymphoid irradiation, the serum albumin level rose in all patients in association with a reduction in the serum level of anti-DNA antibodies, an increase in the serum complement level, or both. Improvement in these variables persisted in eight patients followed for more than 1 year, with the stabilization or reduction of the serum creatinine level. Urinary leakage of albumin was substantially reduced in all patients. Side effects associated with radiotherapy included transient constitutional complaints in ten patients, transient blood element depressions in three, localized viral and bacterial infections in four, and ovarian failure in one. The results suggest that total lymphoid irradiation may provide an alternative to cytotoxic drugs in the treatment of lupus nephritis.
SAMUEL STROBER, ELIZABETH FIELD, RICHARD T. HOPPE, BRIAN L. KOTZIN, OVADIA SHEMESH, EDGAR ENGLEMAN, et al. Treatment of Intractable Lupus Nephritis with Total Lymphoid Irradiation. Ann Intern Med. 1985;102:450–458. doi: 10.7326/0003-4819-102-4-450
Download citation file:
Published: Ann Intern Med. 1985;102(4):450-458.
Autoimmune Kidney Disease, Lupus Erythematosus, Nephrology, Rheumatology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use